文献速递显微修复重建创面修复

累及大血管的肉瘤保肢手术安全性:15年单中心结局研究

Safety of limb-salvaging surgery for sarcomas compromising major vessels: A 15-year single-centre outcomes study.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2021-01-10

结果显示5例发生血管通畅性丧失,其中1例需截肢,5年疾病特异性生存率为58%。作者认为在多学科协作下,血管受累时的保肢手术是安全且功能与心理社会获益的避免截肢手段。

要点

  • 5例重建血管丧失通畅性,其中1例最终截肢。
  • 5年疾病特异性生存率为58%,多学科术前规划是取得良好结局的关键。

核心结论

  • 血管受累时行保肢手术是安全的,且能避免截肢并带来功能与心理社会获益。
  • 周密的术前规划和多学科讨论对获得良好结局至关重要。

研究设计与样本

  • 遵循STROBE规范的回顾性研究,基于前瞻性数据库,纳入2003至2018年因肉瘤切除需行大血管重建的患者。

主要发现

  • 最常见肿瘤部位为大腿和腹股沟区,5例为复发性肿瘤,15例获得清晰切除边缘。
  • 17例首选自体静脉移植而非聚四氟乙烯(PTFE)人工血管。
  • 6例需蒂瓣或游离皮瓣实现充分软组织覆盖,其余行一期闭合。
  • 5例重建血管丧失通畅性,其中1例需截肢。
  • 5年疾病特异性生存率估计为58%。

临床怎么用

  • 对累及大血管的肢体肉瘤,可考虑保肢手术联合血管重建而非直接截肢。
  • 术前多学科讨论和周密规划是取得良好结局的关键。
  • 血管重建时优先考虑自体静脉移植,必要时联合皮瓣覆盖软组织。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Limb-threatening sarcomas invading major vessels present an oncological and reconstructive challenge. Curative resection involves either performing an amputation or an immediate reconstruction of the invaded vessels. We present our 15-year experience of these cases at the North of England Bone and Soft Tissue Tumour Service. MATERIALS AND METHODS: A Strengthening the Reporting of Observational studies in Epidemiology (STROBE) compliant retrospective review of our prospective database was performed including patients who required major vessel reconstruction following sarcoma excision from 2003 until 2018. Patient demographic data along with tumour and histological subtypes, treatment modality, complications and outcomes were inquired. Autologous and prosthetic vessel reconstruction approaches were compared. RESULTS: Nineteen patients were identified with the most common tumour locations being the thigh and groin areas. Five cases involved recurrent tumours. Clear resection margins were obtained in 15 cases. Autologous vein grafts were preferred over polytetrafluoroethylene (PTFE) prosthesis in 17 cases. A pedicled flap or free flap was required to achieve adequate soft tissue cover in six patients, while the rest underwent primary closure. Five patients lost the patency of the reconstructed vessels with one of these requiring an amputation. The estimated disease-specific survival at 5 years was 58%. DISCUSSION: Limb-preservation surgery in the context of vessel compromise is not only safe, but also a functionally and psychosocially beneficial means of avoiding an amputation. We believe that careful pre-operative planning and discussion in a multidisciplinary setting is key for obtaining positive outcomes.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Berner JE, Dearden A, Magdum AA, et al. Safety of limb-salvaging surgery for sarcomas compromising major vessels: A 15-year single-centre outcomes study. J Plast Reconstr Aesthet Surg. 2021. PMID: 33549508. doi:10.1016/j.bjps.2020.12.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。